Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Insulin

Insulin

  • Diabetes (599)
    • Blood Glucose Meters (7)
    • Complications (108)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (73)
    • Drug-Induced Hypo/Hyperglycemia (99)
    • Monitoring (86)
    • Natural Medicines/Supplements (11)
    • Prevention (26)
    • Treatment (217)
      • Alpha-Glucosidase Inhibitors (21)
      • Amylin Agonist (10)
      • Bromocriptine (4)
      • Combination Products (17)
      • Gliptins (63)
      • Glitazones (72)
      • GLP-1 (31)
      • Incretin Enhancers/Mimetics (46)
      • Insulin (128)
      • Meglitinides (32)
      • Metformin (94)
      • SGLT2 Inhibitors (56)
      • Sulfonylureas (80)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (25)
  • Hypoglycemia (23)
  • Other (21)
  • Prediabetes (2)
  • Resources (132)
  • Thyroid Disorders (51)
106 - 120 of 128 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: more emphasis on the prevention and treatment of type 2 diabetes in CHILDREN July 2012
Guideline: Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada July 2012
Commentary: Using Exenatide (Byetta) with Insulin Glargine (Lantus) December 2011
Article: avoiding mishaps when dispensing insulin October 2011
Technician Tutorial: Dispensing Insulin October 2011
Article: avoid mix-ups between Rx and OTC insulin products May 2011
Commentary: Insulins March 2010
Commentary: New Drug: Victoza (Liraglutide) March 2010
Commentary: Is Lantus Associated With An Increased Risk of Cancer? August 2009
Chart: Sulfonylurea Dose Comparison August 2009
Commentary: How Much Insulin Is Too Much? January 2009
Article: Is there a maximum dose for Lantus and other insulins January 2009
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes December 2008
Commentary: Updated Treatment Recommendations for Type 2 Diabetes December 2008
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes November 2008
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved